Ethyl 4-(piperazin-1-yl)benzoate → HCID 54116052, compound
Reaction equation
Cl[CH2:2][CH2:3][CH:4]1[O:8][C:7](=[O:9])[N:6]([CH3:10])[CH2:5]1.[CH2:11]([O:13][C:14](=[O:27])[C:15]1[CH:20]=[CH:19][C:18]([N:21]2[CH2:26][CH2:25][NH:24][CH2:23][CH2:22]2)=[CH:17][CH:16]=1)[CH3:12]>>[CH2:11]([O:13][C:14](=[O:27])[C:15]1[CH:16]=[CH:17][C:18]([N:21]2[CH2:22][CH2:23][N:24]([CH2:2][CH2:3][CH:4]3[O:8][C:7](=[O:9])[N:6]([CH3:10])[CH2:5]3)[CH2:25][CH2:26]2)=[CH:19][CH:20]=1)[CH3:12]Participants
3
Procedure
Following the procedure of Example 2, the title compound is prepared from 5-(2-chloroethyl)-3-methyl-2-oxazolidinone and 4-(1-piperazinyl)benzoic acid ethyl ester.
Sources & evidence
- ORD record
- ord-ed82a00264e74026a38d5af216bcf95e
- Source dataset
- uspto-grants-1992_02
- Patent number
- US05086055
Reaction notes
Loading…